Portfolio company
Biopharmaceutical company
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This firm develops small molecule drugs targeting protein regulatory sites to treat patients with cancer and autoimmune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
BlossomHill Therapeutics
This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.
Technology-enabled pharmaceutical company
This company develops small molecule drug candidates using artificial intelligence for the pharmaceutical and biotechnology industries.
Kronos Bio
This biopharmaceutical company develops small molecule therapeutics targeting transcription factors for patients with cancer and autoimmune diseases.
Biotheryx
The company develops protein degrader medicines for patients with cancer and inflammatory diseases.
HotSpot Therapeutics
The company develops allosteric small molecule medicines for patients with cancer and autoimmune diseases by targeting natural regulatory pockets on proteins.
Principia Biopharma
The company develops oral small molecule therapies for patients with immune-mediated diseases and cancer.
Acerta Pharma
This biopharmaceutical company develops covalent binding medicines for patients with blood cancers and autoimmune diseases.